Wedge Capital Management’s Select Medical SEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-186,250
| Closed | -$2.77M | – | 551 |
|
|
2025
Q4 | $2.77M | Buy |
186,250
+107
| +0.1% | +$1.51K | 0.05% | 292 |
|
|
2025
Q3 | $2.39M | Buy |
186,143
+24,348
| +15% | +$324K | 0.04% | 317 |
|
|
2025
Q2 | $2.46M | Buy |
161,795
+24,685
| +18% | +$385K | 0.04% | 292 |
|
|
2025
Q1 | $2.29M | Buy |
137,110
+19,061
| +16% | +$351K | 0.04% | 296 |
|
|
2024
Q4 | $2.23M | Sell |
118,049
-13,957
| -11% | -$269K | 0.04% | 306 |
|
|
2024
Q3 | $2.48M | Buy |
132,006
+12,212
| +10% | +$234K | 0.04% | 297 |
|
|
2024
Q2 | $2.26M | Sell |
119,794
-19,597
| -14% | -$334K | 0.04% | 298 |
|
|
2024
Q1 | $2.26M | Buy |
139,391
+55,323
| +66% | +$810K | 0.04% | 309 |
|
|
2023
Q4 | $1.06M | Buy |
84,068
+9,516
| +13% | +$120K | 0.02% | 354 |
|
|
2023
Q3 | $1.02M | Sell |
74,552
-113,791
| -60% | -$1.76M | 0.02% | 350 |
|
|
2023
Q2 | $3.23M | Buy |
188,343
+172,432
| +1,084% | +$2.67M | 0.05% | 318 |
|
|
2023
Q1 | $222K | Sell |
15,911
-51
| -0.3% | -$751 | ﹤0.01% | 393 |
|
|
2022
Q4 | $214K | Buy |
+15,962
| New | +$206K | ﹤0.01% | 392 |
|
|
2022
Q1 | – | Sell |
-13,920
| Closed | -$221K | – | 444 |
|
|
2021
Q4 | $221K | Hold |
13,920
| – | – | ﹤0.01% | 381 |
|
|
2021
Q3 | $271K | Buy |
13,920
+4,675
| +51% | +$92.8K | ﹤0.01% | 353 |
|
|
2021
Q2 | $210K | Buy |
+9,245
| New | +$192K | ﹤0.01% | 377 |
|
|
2021
Q1 | – | Sell |
-16,659
| Closed | -$248K | – | 581 |
|
|
2020
Q4 | $248K | Sell |
16,659
-4,459
| -21% | -$58.2K | ﹤0.01% | 499 |
|
|
2020
Q3 | $237K | Sell |
21,118
-17,227
| -45% | -$170K | ﹤0.01% | 473 |
|
|
2020
Q2 | $304K | Buy |
+38,345
| New | +$318K | ﹤0.01% | 421 |
|
|
2015
Q3 | – | Sell |
-49,741
| Closed | -$434K | – | 611 |
|
|
2015
Q2 | $434K | Buy |
49,741
+6,218
| +14% | +$52.2K | ﹤0.01% | 465 |
|
|
2015
Q1 | $348K | Buy |
43,523
+6,032
| +16% | +$45.1K | ﹤0.01% | 497 |
|
|
2014
Q4 | $291K | Sell |
37,491
-5,151
| -12% | -$37.6K | ﹤0.01% | 528 |
|
|
2014
Q3 | $276K | Buy |
42,642
+12,157
| +40% | +$93.9K | ﹤0.01% | 535 |
|
|
2014
Q2 | $256K | Buy |
30,485
+9,327
| +44% | +$72.3K | ﹤0.01% | 534 |
|
|
2014
Q1 | $142K | Sell |
21,158
-4,037
| -16% | -$24.5K | ﹤0.01% | 495 |
|
|
2013
Q4 | $158K | Sell |
25,195
-7,378
| -23% | -$36K | ﹤0.01% | 488 |
|
|
2013
Q3 | $142K | Buy |
32,573
+696
| +2% | +$3.18K | ﹤0.01% | 478 |
|
|
2013
Q2 | $141K | Buy |
+31,877
| New | +$141K | ﹤0.01% | 481 |
|
Other funds holding SEM
GCL
Wedge Capital Management's SEM Position: Q1 2026 in Review
Wedge Capital Management sold out of Select Medical (SEM) in Q1 2026, closing a stake of 186,250 shares — an estimated $2.77M sold.
Wedge Capital Management first reported a position in SEM in Q2 2013 and held it in 28 quarters. The position peaked at $3.23M in Q2 2023. 278 funds tracked by Wall St. Rank hold SEM as of Q1 2026.
- Wedge Capital Management reported no remaining Select Medical position as of Q1 2026 after selling out during the quarter.
- Wedge Capital Management sold 186,250 Select Medical shares in Q1 2026, an estimated $2.77M.
- Wedge Capital Management first reported a position in Select Medical in Q2 2013 and held it in 28 quarters.
- Wedge Capital Management's Select Medical position peaked at $3.23M in Q2 2023.
- 278 funds tracked by Wall St. Rank held Select Medical as of Q1 2026.
Based on Wedge Capital Management's 13F filing for Q1 2026, filed 13 Apr 2026.